Pembrolizumab May Be Preferable to Chemo in Certain Patients
NEW YORK (Reuters Health) – Pembrolizumab may have an edge on chemotherapy for microsatellite instability-high (MSI-H) advanced gastric or gastroesophageal-junction […]
NEW YORK (Reuters Staff) – Using serum metabolomics profiling, researchers have identified two metabolites that are associated with risk for […]biological marker
Serum Biomarkers of Increased Risk for Second Primary Lung Cancer Identified